Intrauterine Devices Market

Category : Healthcare & Life Sciences Reports | Delivery Format : PDF,PPT | Publisher: Reports and Insights | Pages : 150

To learn more about this report, request a free sample copy

Intrauterine Devices Market Overview

The report is titled as ‘Intrauterine Devices Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the intrauterine devices market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The intrauterine devices market is expected to grow at a significant rate in the near future.

The global intrauterine devices market in 2020 is estimated for more than US$ 4.1 Bn and expected to reach a value of US$ 5.9 Bn by 2028 with a significant CAGR of 4.5%.

Intrauterine Devices Introduction

Intrauterine devices or IUDs are contraceptive medical devices that are used to prevent pregnancy over a period of time. Intrauterine devices are intended for birth control or family planning and prevent unwanted pregnancies. Intrauterine devices act by long-acting reversible contraception that is proven to be 99% effective and safe. There is a number of intrauterine device products in the pipeline which are expected to be launched in the market during the forecast period. However, the availability of a limited number of approved devices limits the widespread use of these devices across the globe. Some of the examples of approved IUDs in the U.S. include Mirena, Jaydess, Kyleena, Liletta, Skyla, etc.

Intrauterine Devices Market Dynamics

Intrauterine devices are quickly gaining attention due to the growing incidence of unintended pregnancies and sexually transmitted diseases it helps to control huge healthcare expenditure on abortions and other health complications of STDs. According to the World Health Organization (WHO) approximately 60% 0f pregnancies in the U.S. are unintended and mistimed. Governments of developed and developing countries are also taking measures to promote the use of intrauterine devices which is expected to drive the growth of the global intrauterine devices market. However, unawareness of the function of intrauterine devices in developing and underdeveloped countries is the factor restraining the growth of the global market.

Intrauterine Devices Market Key Players

The global intrauterine devices market is highly consolidated and is mainly dominated by Pfizer Inc., Agile Therapeutics, Allergan Inc., Bayer AG, Teva Pharmaceutical Company Limited, etc.

Intrauterine Devices Market Segmentation

The global intrauterine devices market is segmented on the basis of product type, distribution channel, and region. On the basis of devices, the global intrauterine devices market can be segmented into copper devices (inert IUDs) and hormonal devices. On the basis of distribution channels, the global intrauterine devices market can be segmented into hospitals, ambulatory surgical centers, obstructive and gynecology clinics, government and non-profit organizations (e.g. WHO), etc.

The global intrauterine devices market is expected to increase at a significant CAGR over the forecast period owing number of new FDA approval and growing penetration of cardiac ablation procedures in the U.S. and other matured markets.

Intrauterine Devices Market Regional Overview & Analysis

On the basis of region, the global intrauterine devices market is segmented into six regions namely North America, Latin America, Asia Pacific, Europe, Middle East, and Africa. North America intrauterine devices market is expected to be the most dominating market throughout the forecast period due to new product launches.

MMC Overview on Intrauterine Devices Market Report

The non-identical approach of Reports and Insights stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.

A research report on the Intrauterine Devices market by Reports and Insights is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that supports market and the factors that are acting as impedance for the growth of the market.

Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

•    New product designs and launches

•    Current product compliance

•    Reimbursement

•    Concerns for use of Intrauterine Devices

•    Advantage of Intrauterine Devices

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.


To learn more about this report, request a free sample copy


1.    Global Intrauterine Devices Report Overview

1.1.    Introduction

1.2.    Report Description

1.3.    Methodology

2.    Global Intrauterine Devices Overview

2.1.    Introduction

2.1.1.    Introduction

2.1.2.    Market Taxonomy

2.2.    Executive Summary

2.3.    Global Intrauterine Devices Snapshot

2.4.    Global Intrauterine Devices Size and Forecast, 2020–2028

2.4.1.    Introduction

2.4.2.    Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)

2.5.    Global Intrauterine Devices Dynamics

2.5.1.    Drivers

2.5.2.    Restraints

2.5.3.    Opportunity

2.5.4.    Trends

2.6.    Key Regulations

2.7.    Porter’s Five Forces Model

3.    Global Intrauterine Devices, By Devices

3.1.    Introduction

3.1.1.    Annual Growth Rate Comparison, By Devices

3.1.2.    BPS Analysis, By Devices

3.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Devices

3.2.1.    Copper Devices (Inert Iuds)

3.2.2.    Hormonal Devices

3.3.    Global Intrauterine Devices Attractiveness Index, By Devices

4.    Global Intrauterine Devices, By Distribution Channel

4.1.    Introduction

4.1.1.    Annual Growth Rate Comparison, By Distribution Channel

4.1.2.    BPS Analysis, By Distribution Channel

4.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Distribution Channel

4.2.1.    Hospitals

4.2.2.    Ambulatory Surgical Centers

4.2.3.    Obstructive And Gynaecology Clinics

4.2.4.    Government And Non-Profit Organizations

4.3.    Global Intrauterine Devices Attractiveness Index, By Distribution Channel

5.    Global Intrauterine Devices, By Region

5.1.    Introduction

5.1.1.    Annual Growth Rate Comparison, By Region

5.1.2.    BPS Analysis, By Region

5.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Region

5.2.1.    North America

5.2.2.    Latin America

5.2.3.    Europe

5.2.4.    Asia Pacific

5.2.5.    Middle East and Africa

5.3.    Global Intrauterine Devices Attractiveness Index, By Region

6.    North America Intrauterine Devices Analysis and Forecast, 2019–2027

6.1.    Introduction

6.1.1.    Annual Growth Rate Comparison, By Country

6.1.2.    BPS Analysis, By Country

6.2.    Market Revenue (US$Mn) and Volume (Units) Forecast, By Country

6.2.1.    U.S. Intrauterine Devices

6.2.2.    Canada Intrauterine Devices

6.3.    North America Intrauterine Devices, By Devices

6.3.1.    Copper Devices (Inert Iuds)

6.3.2.    Hormonal Devices

6.4.    North America Intrauterine Devices, By Distribution Channel

6.4.1.    Hospitals

6.4.2.    Ambulatory Surgical Centers

6.4.3.    Obstructive And Gynaecology Clinics

6.4.4.    Government And Non-Profit Organizations

6.5.    North America Intrauterine Devices Attractiveness Index

6.5.1.    By Country

6.5.2.    By Devices

6.5.3.    By Distribution Channel

7.    Latin America Intrauterine Devices Analysis and Forecast, 2020–2028

7.1.    Introduction

7.1.1.    Annual Growth Rate Comparison, By Country

7.1.2.    BPS Analysis, By Country

7.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

7.2.1.    Brazil Intrauterine Devices

7.2.2.    Mexico Intrauterine Devices

7.2.3.    Argentina Intrauterine Devices

7.2.4.    Rest of Latin America Intrauterine Devices

7.3.    Latin America Intrauterine Devices, By Devices

7.3.1.    Copper Devices (Inert Iuds)

7.3.2.    Hormonal Devices

7.4.    Latin America Intrauterine Devices, By Distribution Channel

7.4.1.    Hospitals

7.4.2.    Ambulatory Surgical Centers

7.4.3.    Obstructive And Gynaecology Clinics

7.4.4.    Government And Non-Profit Organizations

7.5.    Latin America Intrauterine Devices Attractiveness Index

7.5.1.    By Country

7.5.2.    By Devices

7.5.3.    By Distribution Channel

8.    Europe Intrauterine Devices Analysis and Forecast, 2020–2028

8.1.    Introduction

8.1.1.    Annual Growth Rate Comparison, By Country

8.1.2.    BPS Analysis, By Country

8.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

8.2.1.    U.K. Intrauterine Devices

8.2.2.    Germany Intrauterine Devices

8.2.3.    Italy Intrauterine Devices

8.2.4.    France Intrauterine Devices

8.2.5.    Spain Intrauterine Devices

8.2.6.    Russia Intrauterine Devices

8.2.7.    Poland Intrauterine Devices

8.2.8.    BENELUX Intrauterine Devices

8.2.9.    NORDIC Intrauterine Devices

8.2.10.    Rest of Europe Intrauterine Devices

8.3.    Europe Intrauterine Devices, By Devices

8.3.1.    Copper Devices (Inert Iuds)

8.3.2.    Hormonal Devices

8.4.    Europe Intrauterine Devices, By Distribution Channel

8.4.1.    Hospitals

8.4.2.    Ambulatory Surgical Centers

8.4.3.    Obstructive And Gynaecology Clinics

8.4.4.    Government And Non-Profit Organizations

8.5.    Europe Intrauterine Devices Attractiveness Index

8.5.1.    By Country

8.5.2.    By Devices

8.5.3.    By Distribution Channel

9.    Asia Pacific Intrauterine Devices Analysis and Forecast, 2020–2028

9.1.    Introduction

9.1.1.    Annual Growth Rate Comparison, By Country

9.1.2.    BPS Analysis, By Country

9.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

9.2.1.    China Intrauterine Devices

9.2.2.    India Intrauterine Devices

9.2.3.    Japan Intrauterine Devices

9.2.4.    Australia and New Zealand Intrauterine Devices

9.2.5.    South Korea Intrauterine Devices

9.2.6.    ASEAN Intrauterine Devices

9.2.7.    Rest of Asia Pacific Intrauterine Devices

9.3.    Asia Pacific Intrauterine Devices, By Devices

9.3.1.    Copper Devices (Inert Iuds)

9.3.2.    Hormonal Devices

9.4.    Asia Pacific Intrauterine Devices, By Distribution Channel

9.4.1.    Hospitals

9.4.2.    Ambulatory Surgical Centers

9.4.3.    Obstructive And Gynaecology Clinics

9.4.4.    Government And Non-Profit Organizations

9.5.    Asia Pacific Intrauterine Devices Attractiveness Index

9.5.1.    By Country

9.5.2.    By Devices

9.5.3.    By Distribution Channel

10.    Middle East Intrauterine Devices, By Region

10.1.    Introduction

10.1.1.    Annual Growth Rate Comparison, By Country

10.1.2.    BPS Analysis, By Country

10.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

10.2.1.    GCC Countries Intrauterine Devices

10.2.2.    Israel Intrauterine Devices

10.2.3.    Oman Intrauterine Devices

10.2.4.    Rest of Middle East Intrauterine Devices

10.3.    Middle East Intrauterine Devices, By Devices

10.3.1.    Copper Devices (Inert Iuds)

10.3.2.    Hormonal Devices

10.4.    Middle East Intrauterine Devices, By Distribution Channel

10.4.1.    Hospitals

10.4.2.    Ambulatory Surgical Centers

10.4.3.    Obstructive And Gynaecology Clinics

10.4.4.    Government And Non-Profit Organizations

10.5.    Middle East Intrauterine Devices Attractiveness Index

10.5.1.    By Country

10.5.2.    By Devices

10.5.3.    By Distribution Channel

11.    Africa Intrauterine Devices, By Region

11.1.    Introduction

11.1.1.    Annual Growth Rate Comparison, By Country

11.1.2.    BPS Analysis, By Country

11.2.    Market (US$Mn) and Volume (Units) Forecast, By Country

11.2.1.    South Africa Intrauterine Devices

11.2.2.    Egypt Intrauterine Devices

11.2.3.    North Africa Intrauterine Devices

11.2.4.    Rest of Africa Intrauterine Devices

11.3.    Africa Intrauterine Devices, By Devices

11.3.1.    Copper Devices (Inert Iuds)

11.3.2.    Hormonal Devices

11.4.    Africa Intrauterine Devices, By Distribution Channel

11.4.1.    Hospitals

11.4.2.    Ambulatory Surgical Centers

11.4.3.    Obstructive And Gynaecology Clinics

11.4.4.    Government And Non-Profit Organizations

11.5.    Africa Intrauterine Devices Attractiveness Index

11.5.1.    By Country

11.5.2.    By Devices

11.5.3.    By Distribution Channel

12.    Recommendation

12.1.    Market Strategy

13.    Competitive Landscape

13.1.    Competition Dashboard

13.2.    List and Company Overview of Global Key Players

13.3.    Company Profiles

13.3.1.    Pfizer Inc.

13.3.1.1.    Company Overview

13.3.1.2.    Financial Overview

13.3.1.3.    Product Portfolio

13.3.1.4.    Key Developments

13.3.1.5.    Business Strategies

13.3.2.    Agile Therapeutics

13.3.3.    Allergan Inc.

13.3.4.    Bayer AG

13.3.5.    Teva Pharmaceutical Company Limited

13.3.6.    Besins HealthCare 

13.3.7.    Brecuro Medical

13.3.8.    Effik International 

13.3.9.    Eurogine 

13.3.10.    HLL Lifecare

13.3.11.    HRA Pharma

13.3.12.    Medisafe Distribution

13.3.13.    OCON Medical

13.3.14.    Pregna

13.3.15.    SMB

14.    Acronyms

Select License Type

Frequently Asked Questions

The global intrauterine devices market in 2020 is estimated for more than US$ 4.1 Bn and expected to reach a value of US$ 5.9 Bn by 2028 with a significant CAGR of 4.5%.

Intrauterine devices are quickly gaining attention due to the growing incidence of unintended pregnancies and sexually transmitted diseases it helps to control huge healthcare expenditure on abortions and other health complications of STDs

The global intrauterine devices market is segmented on the basis of product type, distribution channel, and region

The global intrauterine devices market is highly consolidated and is mainly dominated by Pfizer Inc., Agile Therapeutics, Allergan Inc., Bayer AG, Teva Pharmaceutical Company Limited, etc.



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy

OK